Marathon Petroleum Corp vs Sanofi SA — how do they compare? Marathon Petroleum Corp trades at $318.36 (market cap $92.05B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Marathon Petroleum Corp and Sanofi SA are close in size by market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| MPC | SNY | |
|---|---|---|
Market Cap | $92.05B | $104.83B |
Sector | Energy | Health |
52-Week High | $315.31 | $52.34 |
52-Week Low | $158.59 | $41.33 |
Enterprise Value | $124.23B | $121.32B |
Dividend Yield | 1.24% | 5.5% |
Trailing returns across standard periods
Latest headlines on both assets
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →